High levels of TIGIT expression can inhibit IFN-γ production by NK cells, while blockade of TIGIT can restore their function, suggesting targeting of TIGIT as a potential immune therapeutic strategy for treatment of HIV infection. The gene discussed is IFNG; the disease is HIV infectious disease.